Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02
Lester J. Peters(Peter MacCallum Cancer Centre), Danny Rischin(Peter MacCallum Cancer Centre), Richard Fisher(Princess Margaret Cancer Centre), Brian O’Sullivan(University of Toronto), Andy Trotti, Thomas J. FitzGerald(University of Massachusetts Chan Medical School), Jean Bourhis(University of Lausanne), Kally Yuen(Princess Margaret Cancer Centre), Jacques Bernier(Ospedale San Giovanni Bellinzona), J. Giralt(Vall d'Hebron Hospital Universitari)
Cited by 806
Related Papers
Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)
|Head & Neck|2005|1.8k
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial
|The Lancet|2002|1.7k
Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin
|New England Journal of Medicine|1997|1.6k
Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|1990|1.4k